Thursday, March 07, 2013 2:21:45 PM
Compensated Awareness Post View
Disclaimer
Thursday New Surf Alert $IMMB Profile
IMMB - Immunotech Laboratories, Inc.
Immunotech -Business OverView
Website - http://www.immunotechlab.com
Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Immunotech is committed to creating drugs for the better health of mankind.
After decades of research, we determined that it was time to take Immunotech Laboratories, Inc. (formerly International Technology Systems, Inc.) and our product to the next level. Therefore, we are glad to inform you that Immunotech Laboratories, Inc. is currently trading publicly under the ticker symbol of IMMB (Pink Sheets / OTC.NASDAQ Exchange).
Immunotech’s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
Products and Services
http://www.immunotechlab.com/our-products
IMMB Flagship Product
Immune Therapeutic Vaccine-1 (ITV-1)
Immunotech’s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction
(IPF), which studies have shown is effective in the treatment
of HIV/AIDS. IPF is the active drug substance of ITV-1 and
is a purified extract of porcine pepsin. ITV-1 has been shown
to modulate the immune system.
In Harry Zhabilov’s paper, Immune Therapeutic Vaccine (ITV): A Fusion Inhibitor and Immunomodulator, our Chief Science Officer details his motivation for exploring this therapeutic avenue,
and the promising results of extensive laboratory testing.
Irreversible Pepsin Fraction (IPF)
Irreversible Pepsin Fraction (IPF) is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.
MSD Platform
http://www.immunotechlab.com/msd-platform
Pipeline
http://www.immunotechlab.com/pipeline
ITV-2 Prenatal
ITV-2 will utilize Immunotech Laboratories’ IPF platform technology. This product’s testing is scheduled to begin soon. Come back soon for more information and updates on this exciting product.
ITV-3 Pediatric
ITV-3 will utilize Immunotech Laboratories’ IPF platform technology. This product’s testing is scheduled to begin soon. Come back soon for more information and updates on this exciting product.
ITV-4 HIV Vaccine
Preclinical developement for the ITV-4 HIV Vaccine is scheduled to begin in the 4th Quarter of 2012.
Immunotech Laboratories, Inc. is publicly traded on the OTC Market under the symbol, “IMMB”, and within the OTC Pink Limited Information market tier. As such, Business, Operational, and Financial information on IMMB is available to public view.
Visit: http://www.otcmarkets.com/stock/IMMB/company-info to see complete details.
A/S: 3 Billion
O/S: 60 Million
(Please note the share structure posted is what we have gathered but can change on a daily basis. Contact the Company or Transfer Agent to get the most current information.)
Incorporated In: Nevada in 2009
Interstate Transfer Co.
6084 South 900 East
Suite 101
Salt Lake City, UT 84121
Phone: 801-281-9746
Email: Jillitc@zzlink.net
Website: http://www.interstatetransfer.com
News Disclaimer - The following Press Releases have not been investigated by Wall Street Surfers, therefore we have no idea if the content of this news is based on Fact or Fiction. Although the links for the following press releases may be from a familiar and reputable company, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. Wall Street Surfers will not be held responsible for any news release including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.
Marketwire - (March 1)
Immunotech Relocates to New Research & Development Laboratory Facility
http://finance.yahoo.com/news/immunotech-relocates-research-development-laboratory-141500581.html
PR Newswire - (February 20)
Immunotech Laboratories Inc. Announces Clinical Trials Updates For Company's AIDS-HIV "IPF" Medicines
http://finance.yahoo.com/news/immunotech-laboratories-inc-announces-clinical-183200464.html
Marketwire - (February 19)
Immunotech Laboratories, Inc. Announces Analyst Report Issued by Market Advisors, Inc.
http://finance.yahoo.com/news/immunotech-laboratories-inc-announces-analyst-141500569.html
PR Newswire - (February 13)
Immunotech Laboratories Receives $2M Funding Approval To Begin European Clinical Trials Testing For Company's Patented "IPF" HIV-AIDS Medicines
http://finance.yahoo.com/news/immunotech-laboratories-receives-2m-funding-142000938.html
Contact Us:
Immunotech Laboratories, Inc.
120 W. Pomona Avenue
Monrovia, CA 91016
Fax/Phone:
Fax: 818-409-8988
Telephone: 818-409-8988
Investor Relations:
ir@immunotechlab.com
General Inquiry:
info@immunotechlab.com
This Alert Brought to you by Wall Street Surfers
Newsletter Sign Up - http://www.wallstreetsurfers.com
Penny Stocks are very volatile and with investing in any security there is always risk.
Always Educate yourself and do your own Due Diligence before investing in ANY Security.
Sources: http://www.bloomberg.com - http://www.finance.yahoo.com - http://www.businessweek.com - http://www.otcmarkets.com/marketActivity/current-otc-market
(these are only sources and not always up to date)
If you are new to trading penny stocks we strongly advise you to spend some time trading virtual money. They say that “You never really become a real trader until you wipeout your portfolio.” We say take that wipeout while not losing your real money.
Here are a few sites where you can easily set up a virtual account:
First check your broker, some have them already like TD Ameritrade/Think or Swim
https://www.tdameritrade.com/tradingtools/compareplatforms.html
Howthemarketworks.com
http://www.howthemarketworks.com
Wallstreetsurvivors.com
http://www.wallstreetsurvivor.com
IMMB - Immunotech Laboratories, Inc.
Immunotech -Business OverView
Website - http://www.immunotechlab.com
Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Immunotech is committed to creating drugs for the better health of mankind.
After decades of research, we determined that it was time to take Immunotech Laboratories, Inc. (formerly International Technology Systems, Inc.) and our product to the next level. Therefore, we are glad to inform you that Immunotech Laboratories, Inc. is currently trading publicly under the ticker symbol of IMMB (Pink Sheets / OTC.NASDAQ Exchange).
Immunotech’s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
Products and Services
http://www.immunotechlab.com/our-products
IMMB Flagship Product
Immune Therapeutic Vaccine-1 (ITV-1)
Immunotech’s flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction
(IPF), which studies have shown is effective in the treatment
of HIV/AIDS. IPF is the active drug substance of ITV-1 and
is a purified extract of porcine pepsin. ITV-1 has been shown
to modulate the immune system.
In Harry Zhabilov’s paper, Immune Therapeutic Vaccine (ITV): A Fusion Inhibitor and Immunomodulator, our Chief Science Officer details his motivation for exploring this therapeutic avenue,
and the promising results of extensive laboratory testing.
Irreversible Pepsin Fraction (IPF)
Irreversible Pepsin Fraction (IPF) is a platform technology that can be used to facilitate a broad range of applications. It is free from neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.
MSD Platform
http://www.immunotechlab.com/msd-platform
Pipeline
http://www.immunotechlab.com/pipeline
ITV-2 Prenatal
ITV-2 will utilize Immunotech Laboratories’ IPF platform technology. This product’s testing is scheduled to begin soon. Come back soon for more information and updates on this exciting product.
ITV-3 Pediatric
ITV-3 will utilize Immunotech Laboratories’ IPF platform technology. This product’s testing is scheduled to begin soon. Come back soon for more information and updates on this exciting product.
ITV-4 HIV Vaccine
Preclinical developement for the ITV-4 HIV Vaccine is scheduled to begin in the 4th Quarter of 2012.
Immunotech Laboratories, Inc. is publicly traded on the OTC Market under the symbol, “IMMB”, and within the OTC Pink Limited Information market tier. As such, Business, Operational, and Financial information on IMMB is available to public view.
Visit: http://www.otcmarkets.com/stock/IMMB/company-info to see complete details.
A/S: 3 Billion
O/S: 60 Million
(Please note the share structure posted is what we have gathered but can change on a daily basis. Contact the Company or Transfer Agent to get the most current information.)
Incorporated In: Nevada in 2009
Interstate Transfer Co.
6084 South 900 East
Suite 101
Salt Lake City, UT 84121
Phone: 801-281-9746
Email: Jillitc@zzlink.net
Website: http://www.interstatetransfer.com
News Disclaimer - The following Press Releases have not been investigated by Wall Street Surfers, therefore we have no idea if the content of this news is based on Fact or Fiction. Although the links for the following press releases may be from a familiar and reputable company, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. Wall Street Surfers will not be held responsible for any news release including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.
Marketwire - (March 1)
Immunotech Relocates to New Research & Development Laboratory Facility
http://finance.yahoo.com/news/immunotech-relocates-research-development-laboratory-141500581.html
PR Newswire - (February 20)
Immunotech Laboratories Inc. Announces Clinical Trials Updates For Company's AIDS-HIV "IPF" Medicines
http://finance.yahoo.com/news/immunotech-laboratories-inc-announces-clinical-183200464.html
Marketwire - (February 19)
Immunotech Laboratories, Inc. Announces Analyst Report Issued by Market Advisors, Inc.
http://finance.yahoo.com/news/immunotech-laboratories-inc-announces-analyst-141500569.html
PR Newswire - (February 13)
Immunotech Laboratories Receives $2M Funding Approval To Begin European Clinical Trials Testing For Company's Patented "IPF" HIV-AIDS Medicines
http://finance.yahoo.com/news/immunotech-laboratories-receives-2m-funding-142000938.html
Contact Us:
Immunotech Laboratories, Inc.
120 W. Pomona Avenue
Monrovia, CA 91016
Fax/Phone:
Fax: 818-409-8988
Telephone: 818-409-8988
Investor Relations:
ir@immunotechlab.com
General Inquiry:
info@immunotechlab.com
This Alert Brought to you by Wall Street Surfers
Newsletter Sign Up - http://www.wallstreetsurfers.com
Penny Stocks are very volatile and with investing in any security there is always risk.
Always Educate yourself and do your own Due Diligence before investing in ANY Security.
Sources: http://www.bloomberg.com - http://www.finance.yahoo.com - http://www.businessweek.com - http://www.otcmarkets.com/marketActivity/current-otc-market
(these are only sources and not always up to date)
If you are new to trading penny stocks we strongly advise you to spend some time trading virtual money. They say that “You never really become a real trader until you wipeout your portfolio.” We say take that wipeout while not losing your real money.
Here are a few sites where you can easily set up a virtual account:
First check your broker, some have them already like TD Ameritrade/Think or Swim
https://www.tdameritrade.com/tradingtools/compareplatforms.html
Howthemarketworks.com
http://www.howthemarketworks.com
Wallstreetsurvivors.com
http://www.wallstreetsurvivor.com
IF YOU LIKE THE CHARTS HIT ME UP WITH A PERSON MARK
http://investorshub.advfn.com/boards/profilea.aspx?user=192141
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.